Mepolizumab | Interleukin Related interleukin-related.com

Product Name :
Mepolizumab

Search keywords :
Mepolizumab

drugId :
null

Target Vo:
Interleukin-5

Target Vo Short Name :
IL5

Moa_Name:
Interleukin-5 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2015

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :
Glaxo Operations Uk Ltd

Active Indication_Name:
Asthma

In Active Indication_Name:
Virus Diseases

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
GSDMD Antibody
GSDME Antibody
MRP2/ABCC2 Antibody: MRP2/ABCC2 Antibody is an unconjugated, approximately 174 kDa, rabbit-derived, anti-MRP2/ABCC2 polyclonal antibody. MRP2/ABCC2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, background without labeling.

Author: Interleukin Related

Related Posts